» Articles » PMID: 23884066

Understanding Barriers to Hepatitis C Virus Care and Stigmatization from a Social Perspective

Overview
Journal Clin Infect Dis
Date 2013 Jul 26
PMID 23884066
Citations 71
Authors
Affiliations
Soon will be listed here.
Abstract

A large body of literature emphasizes the relationship between stigma and adverse health outcomes and health access measures. For people living with hepatitis C virus (HCV), stigma is a defining feature given the association of HCV with the socially demonized practice of injection drug use. However, there is little literature that specifically examines stigma as a barrier to HCV care and treatment. This review argues that the relationship between the person living with HCV and their health worker can work to ameliorate the effects of stigma. We draw on an emerging literature that examines the positive association between a patient's "trust" in their health worker and outcomes such as increased healthcare utilization and reduced risk behaviors. We investigate a growing body of health services research that acknowledges the importance of stigma and demonstrates ways to build positive, enabling relationships between patient, health worker, and health setting.

Citing Articles

Distrust in the Health Care System and Adherence to Direct-Acting Antiviral Therapy among People with Hepatitis Who Inject Drugs.

Padi A, Pericot-Valverde I, Heo M, Dotherow J, Niu J, Martin M Viruses. 2024; 16(8.

PMID: 39205278 PMC: 11359142. DOI: 10.3390/v16081304.


The Challenge of a Recall Program from a Community-Based Hepatitis C Screening Campaign: The Effectiveness in HCV Microelimination.

Chien C, Chou T, Chen L, Lin C, Chang J, Liu C Microorganisms. 2024; 12(7).

PMID: 39065170 PMC: 11279112. DOI: 10.3390/microorganisms12071402.


The Application of Australian Rights Protections to the Use of Hepatitis C Notification Data to Engage People 'Lost to Follow Up'.

Saich F, Walker S, Hellard M, Stoove M, Seear K Public Health Ethics. 2024; 17(1-2):40-52.

PMID: 39005529 PMC: 11245707. DOI: 10.1093/phe/phae006.


Using an intersectionality lens to explore barriers and enablers to hepatitis C point-of-care testing: a qualitative study among people who inject drugs and service providers.

Fontaine G, Presseau J, Bruneau J, Etherington C, Thomas I, Hung J Int J Equity Health. 2024; 23(1):124.

PMID: 38886803 PMC: 11184812. DOI: 10.1186/s12939-024-02209-0.


Evaluation of a Project Integrating Financial Incentives into a Hepatitis C Testing and Treatment Model of Care at a Sexual Health Service in Cairns, Australia, 2020-2021.

Dawe J, Gorton C, Lewis R, Richmond J, Wilkinson A, Pedrana A Viruses. 2024; 16(5).

PMID: 38793681 PMC: 11125761. DOI: 10.3390/v16050800.